Hologic (NASDAQ: HOLX) reported Q1 EPS of $0.98, $0.03 better than the analyst estimate of $0.95. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $986.95 million.

GUIDANCE:

Hologic sees Q2 2024 EPS of $0.95-$1.00, versus the consensus of $0.98. Hologic sees Q2 2024 revenue of $0.99-1.01 billion, versus the consensus of $0.99 billion.

Hologic sees FY2024 EPS of $3.97-$4.12, versus the consensus of $4.00. Hologic sees FY2024 revenue of $3.99-4.06 billion, versus the consensus of $3.99 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.